BORDERLINE RESECTABLE PANCREATIC CANCER TREATED WITH CHEMORADIOTHERAPY

Clinical trials for BORDERLINE RESECTABLE PANCREATIC CANCER TREATED WITH CHEMORADIOTHERAPY explained in plain language.

Never miss a new study

Get alerted when new BORDERLINE RESECTABLE PANCREATIC CANCER TREATED WITH CHEMORADIOTHERAPY trials appear

Sign up with your email to follow new studies for BORDERLINE RESECTABLE PANCREATIC CANCER TREATED WITH CHEMORADIOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New combo attack on tough pancreatic tumors

Disease control Ongoing

This early-stage study is testing whether combining a chemotherapy drug (nab-paclitaxel) with higher doses of radiation can better control pancreatic cancer that is difficult or impossible to remove with surgery. The goal is to see if this more intense treatment is safe and can s…

Matched conditions: BORDERLINE RESECTABLE PANCREATIC CANCER TREATED WITH CHEMORADIOTHERAPY

Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control

Last updated Apr 04, 2026 02:20 UTC

BORDERLINE RESECTABLE PANCREATIC CANCER TREATED WITH CHEMORADIOTHERAPY

Get alerted when new BORDERLINE RESECTABLE PANCREATIC CANCER TREATED WITH CHEMORADIOTHERAPY trials appear

New combo attack on tough pancreatic tumors